基于菌体的活生物疗法:一种新的方法来应对耐药性传染病
Kajal Kamboj1, Bhabatosh Das1, Christophe Possoz2
1Microbial Research Centre, BRIC-Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana, India.
Progress in molecular biology and translational science
|February 19, 2026
概括
菌体是向细菌的病毒,为抗菌素耐药性 (AMR) 的上升提供了有效的解决方案. 这些自然捕食者为治疗耐药性感染提供了抗生素的有希望的替代品.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 公共卫生 公共卫生
背景情况:
- 抗菌素耐药性 (AMR) 是日益严重的全球卫生危机,使得多药耐药性 (MDR) 细菌感染难以用常规抗生素治疗.
- 菌体 (菌体) 是感染细菌的病毒,对抗性病原体具有潜在的治疗策略.
- 菌体疗法提供了特异性,在感染部位自我复制,以及生物膜破坏能力.
研究的目的:
- 探索菌体作为抗生素的替代品或辅助剂的治疗潜力,以对抗AMR.
- 突出基于菌体的生物治疗的机制和优势.
- 强调菌体治疗在临床环境中的重要性.
主要方法:
- 审查现有的关于菌体机制和应用的文献.
- 对菌体策略的分析,包括传统疗法,基因工程和菌体-抗生素组合.
- 检查临床试验证据对菌体有效性的证据.
主要成果:
- 菌体在准和消除细菌宿主方面表现出高的特异性.
- 菌体可以适应细菌耐药机制,提供一种动态的治疗方法.
- 临床证据支持菌体作为可行的生物治疗药物的有效性.
结论:
- 菌体在全球抗抗菌性耐药性斗争中是一个强大而适应性的工具.
- 它们的独特特性使得它们成为治疗耐药细菌感染的有希望的解决方案.
- 进一步开发和应用基于菌体的疗法对于公共卫生至关重要.
相关概念视频
Lytic Cycle of Bacteriophages
78.4K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
78.4K
Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Biological Methods for Microbial Control
941
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
941
DNA Bacteriophages
1.1K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.1K
Lysogenic Cycle of Bacteriophages
68.2K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
68.2K
Viral Replication: Lysogenic Cycle
1.8K
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
1.8K


